Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection. [electronic resource]
Producer: 20030418Description: 881-91 p. digitalISSN:- 0903-4641
- Animals
- Antibodies, Bacterial -- biosynthesis
- Antibody Affinity
- Antibody Specificity
- Bacterial Proteins -- immunology
- Biofilms
- Ceftazidime -- therapeutic use
- Chronic Disease
- Enzyme-Linked Immunosorbent Assay
- Female
- Immunization
- Immunization, Secondary
- Immunoglobulin G -- biosynthesis
- Microspheres
- Models, Animal
- Neutralization Tests
- Pneumonia, Bacterial -- drug therapy
- Pseudomonas Infections -- drug therapy
- Pseudomonas aeruginosa -- drug effects
- Rats
- Rats, Inbred Lew
- beta-Lactam Resistance
- beta-Lactamases -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.